{
    "table_name": "quant_phosphoproteome_AML_gilteritinib_resistance_pdc_current",
    "table_fullname": "isb-cgc-bq.CPTAC.quant_phosphoproteome_AML_gilteritinib_resistance_pdc_current",
    "column_names": [
        "case_id",
        "sample_id",
        "aliquot_id",
        "aliquot_submitter_id",
        "aliquot_run_metadata_id",
        "study_name",
        "protein_abundance_log2ratio",
        "refseq_id",
        "phosphorylation_sites"
    ],
    "column_types": [
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "FLOAT64",
        "STRING",
        "STRING"
    ],
    "nested_column_names": [
        "case_id",
        "sample_id",
        "aliquot_id",
        "aliquot_submitter_id",
        "aliquot_run_metadata_id",
        "study_name",
        "protein_abundance_log2ratio",
        "refseq_id",
        "phosphorylation_sites"
    ],
    "nested_column_types": [
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "STRING",
        "FLOAT64",
        "STRING",
        "STRING"
    ],
    "description": [
        "Unique identifier associated with a specific patient (e.g. 24cb0fcb-63d6-11e8-bcf1-0a2705229b82)",
        "Unique PDC identifier for this sample (e.g. e8d83eb9-693a-11ea-b1fd-0aad30af8a83)",
        "Unique PDC identifier for this aliquot (e.g. e8db124a-693a-11ea-b1fd-0aad30af8a83)",
        "Aliquot submitter id assigned by program (e.g. T14)",
        "Uniquely identifies the aliquot by how it was used in the experiment (based on the labelling reagent and/or biological replicate)",
        "Name of the study (e.g. Pediatric Brain Cancer Pilot Study - Phosphoproteome)",
        "Average log-ratio of sample reporter-ion to common reference of peptide ions associated with the gene in acquisitions from a specific biological sample",
        "Unique identifier given to a sequence in the NCBI RefSeq database",
        "Single letter codes and protein sequence positions of the phosphorylated amino acids (e.g. t304s310, t59)"
    ],
    "sample_rows": [
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "baf671ff-e1b6-4cd9-9dfd-5d263db4f5df",
            "aliquot_id": "e8cd8b54-b66a-47da-879f-f135582ea0f5",
            "aliquot_submitter_id": "PTRC_exp12_01",
            "aliquot_run_metadata_id": "85a47ee9-272b-49f0-8f06-eb8ee580eb84",
            "study_name": "AML Gilteritinib Resistance -  Phosphoproteome",
            "protein_abundance_log2ratio": -0.1025,
            "refseq_id": "NP_001005751.1",
            "phosphorylation_sites": "s1075"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "baf671ff-e1b6-4cd9-9dfd-5d263db4f5df",
            "aliquot_id": "e8cd8b54-b66a-47da-879f-f135582ea0f5",
            "aliquot_submitter_id": "PTRC_exp12_01",
            "aliquot_run_metadata_id": "85a47ee9-272b-49f0-8f06-eb8ee580eb84",
            "study_name": "AML Gilteritinib Resistance -  Phosphoproteome",
            "protein_abundance_log2ratio": -0.132,
            "refseq_id": "NP_001005751.1",
            "phosphorylation_sites": "s909"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "baf671ff-e1b6-4cd9-9dfd-5d263db4f5df",
            "aliquot_id": "e8cd8b54-b66a-47da-879f-f135582ea0f5",
            "aliquot_submitter_id": "PTRC_exp12_01",
            "aliquot_run_metadata_id": "85a47ee9-272b-49f0-8f06-eb8ee580eb84",
            "study_name": "AML Gilteritinib Resistance -  Phosphoproteome",
            "protein_abundance_log2ratio": 0.1474,
            "refseq_id": "NP_001014436.1",
            "phosphorylation_sites": "t291"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "baf671ff-e1b6-4cd9-9dfd-5d263db4f5df",
            "aliquot_id": "e8cd8b54-b66a-47da-879f-f135582ea0f5",
            "aliquot_submitter_id": "PTRC_exp12_01",
            "aliquot_run_metadata_id": "85a47ee9-272b-49f0-8f06-eb8ee580eb84",
            "study_name": "AML Gilteritinib Resistance -  Phosphoproteome",
            "protein_abundance_log2ratio": -0.5073,
            "refseq_id": "NP_001014972.1",
            "phosphorylation_sites": "s636"
        },
        {
            "case_id": "4a4b2172-550c-4dbd-adad-8b3425f3ddea",
            "sample_id": "baf671ff-e1b6-4cd9-9dfd-5d263db4f5df",
            "aliquot_id": "e8cd8b54-b66a-47da-879f-f135582ea0f5",
            "aliquot_submitter_id": "PTRC_exp12_01",
            "aliquot_run_metadata_id": "85a47ee9-272b-49f0-8f06-eb8ee580eb84",
            "study_name": "AML Gilteritinib Resistance -  Phosphoproteome",
            "protein_abundance_log2ratio": 0.6132,
            "refseq_id": "NP_001025006.1",
            "phosphorylation_sites": "s185"
        }
    ]
}